Ph.D. David W. Osborne - 21 Apr 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Chief Technical Officer
Signature: /s/ Scott Burrows, as Attorney-in-Fact for David W. Osborne, Ph.D.
Issuer symbol: ARQT
Transactions as of: 21 Apr 2022
Net transactions value: -$44,872
Form type: 4
Filing time: 21 Apr 2022, 18:32:59 UTC
Previous filing: 07 Mar 2022
Next filing: 12 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARQT	Common Stock	Sale	$44,872	-2,197	-0.85%	$20.42	257,229	21 Apr 2022	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2	The transaction was executed in multiple trades in prices ranging from $20.125 to $20.925, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	Includes 24,925 RSUs.